https://www.selleckchem.com/pr....oducts/Idarubicin.ht
To study the safety and efficacy of bi-optics using Implantable Collamer lens (ICL) followed by SMILE for management of extreme myopia. Nethradhama Superspeciality Eye Hospital, Bangalore, India. Retrospective case series METHODS Data was analysed for patients who underwent bi-optics using ICL in the first stage, and SMILE in the second stage for correction of the residual refractive error. Mean interval between stage 1 and stage 2 correction was 24.2±13.33 days. Mean follow-up after the SMILE procedure was 12.26±1.39 (11-14) months.
Gefällt mir
Kommentar
Teilen
